Menu Search
Equities

Jubilant Ingrevia Ltd

JUBLINGREA:NSI

Jubilant Ingrevia Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)712.05
  • Today's Change-29.95 / -4.04%
  • Shares traded193.17k
  • 1 Year change+70.22%
  • Beta1.1127
Data delayed at least 15 minutes, as of Nov 08 2024 10:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy1
Outperform1
Hold1
Sell0
Strong Sell0

Share price forecast in INR

The 3 analysts offering 12 month price targets for Jubilant Ingrevia Ltd have a median target of 695.00, with a high estimate of 849.00 and a low estimate of 600.00. The median estimate represents a -2.52% decrease from the last price of 713.00.
High19.1%849.00
Med-2.5%695.00
Low-15.8%600.00

Dividends

In 2024, Jubilant Ingrevia Ltd reported a dividend of 5.00 INR, equaling last years dividend. The 2 analysts covering the company expect dividends of 3.65 INR for the upcoming fiscal year, a decrease of 27.00%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in INR

Jubilant Ingrevia Ltd reported annual 2024 earnings of 11.55 per share on May 14, 2024.
Average growth rate-37.88%
More ▼

Revenue history & estimates in INR

Jubilant Ingrevia Ltd had 2nd quarter 2025 revenues of 10.45bn. This missed the 10.66bn estimate of the one analyst following the company. This was 2.77% below the prior year's 2nd quarter results.
Average growth rate+0.83%
Jubilant Ingrevia Ltd had revenues for the full year 2024 of 41.36bn. This was 13.34% below the prior year's results.
Average growth rate-8.46%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.